Afamelanotide and NB-UVB Phototherapy
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Afamelanotide and NB-UVB Phototherapy, covering 2021-05-21 to 2021-05-21. Get the full timeline:
Most recent: Clinical Trial Update: Afamelanotide and Narrow-Band Ultraviolet B (NB-UVB) Phototherapy in the Treatment of Nonsegmental Vitiligo (NSV) [Phase 2]